The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 145, Issue , 2015, Pages 28-37

  Wang, Chao ^a   Du, Xiaoling ^a   Yang, Rui ^a   Liu, Jie ^b   Xu, Da ^a   Shi, Jiandang ^a   Chen, Linfeng ^c   Shao, Rui ^a   Fan, Guanwei ^b   Gao, Xiumei ^b   Tian, Guo ^a   Zhu, Yan ^b   Zhang, Ju ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Androgen receptor; Benign prostatic hyperplasia; Cyclins; Oestrogen receptor ; Tanshinone IIA

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CYCLIN B1; CYCLIN D1; DIMETHYL SULFOXIDE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; RNA; TANSHINONE IIA; ABIETANE DERIVATIVE; CYCLIN D; CYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; TANSHINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; RAT; SMOOTH MUSCLE RELAXATION; STROMA CELL; ANIMAL; APOPTOSIS; CELL CYCLE; CELL LINE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PROSTATE; PROSTATIC HYPERPLASIA; WISTAR RAT;

ANDROGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CYCLIN B1; CYCLIN D; CYCLINS; DITERPENES, ABIETANE; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN;

EID: 84908212140     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.09.026     Document Type: Article

References (56)

1. G.H. Kramer, D. Mitteregger, and M. Marberger Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 51 5 2007 1202 1216
2. J.K. Patel, and N.D. Parsons Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction Indian J. Urol. 30 2 2014 170 176
3. J.E. McNeal Origin and evolution of benign prostatic enlargement Invest. Urol. 15 4 1978 340 345
4. S. Claus Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates Urol. Res. 21 5 1993 305 308
5. R. Kumar Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms-action of two new agents Invest. New Drugs 30 2 2012 582 593
6. C.T. Wu Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor Proc. Natl. Acad. Sci. U. S. A. 2007 679 684
7. K. Izumi Androgen receptor roles in the development of benign prostate hyperplasia Am. J. Pathol. 182 6 2013 1942 1949
8. K. Suzuki, and I.S. Takeuchi Endocrinal environment of benign prostatic hyperplasia-relationships of sex steroid hormone levels with age and the size of the prostate Nippon Hinyokika Gakkai Zasshi 83 1992 664 671
9. M. Royuela Estrogen receptors alpha and beta in the normal: hyperplastic and carcinomatous human prostate J. Endocrinol. 168 3 2001 447 454
10. M. Krieg, H. Weisser, and S. Tunn Potential activities of androgen metabolizing enzymes in human prostate J. Steroid Biochem. Mol. Biol. 53 1-6 1995 395 400
11. W.E. Farnsworth Estrogen in the etiopathogenesis of BPH Prostate 41 4 1999 263 274
12. A.R. Lee Isolation and bioactivity of new tanshinones J. Nat. Prod. 50 2 1987 157 160
13. E.H. Cao Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells Free Radic. Biol. Med. 20 6 1996 801 806
14. B.Y. Kang Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza Immunopharmacology 49 3 2000 355 361
15. B. Wei Regulation of antioxidant system: lipids and fatty acid beta-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats Atherosclerosis 230 1 2013 148 156
16. H.J. Sung Tanshinone IIA an ingredient of Salvia miltiorrhiza BUNGE: induces apoptosis in human leukemia cell lines through the activation of caspase-3 Exp. Mol. Med. 31 4 1999 174 178
17. S.L. Yuan Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells World J. Gastroenterol. 10 14 2004 2024 2028
18. Y.H. Su, and C.C. Lin Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios Int. J. Mol. Med. 22 3 2008 357 361
19. S. Yuan A study on apoptosis of nasopharyngeal carcinoma cell line induced by Tanshinone II A and its molecular mechanism Hua Xi Yi Ke Da Xue Xue Bao 33 1 2002 84 90
20. J. Wang Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells J. Neurooncol. 82 1 2007 11 21
21. J.J. Liu Tanshinone IIA inhibits leukemia THP-1 cell growth by induction of apoptosis Oncol. Rep. 21 4 2009 1075 1081
22. J.H. Jung Apoptosis induced by tanshinone iia and cryptotanshinone is mediated by distinct JAK/STAT3/5 and SHP1/2 signaling in chronic myeloid leukemia K562cells Evid. Based Complement. Alternat. Med. 2013 2013 10
23. S.M. Yun Activation of c-Jun N-terminal kinase mediates tanshinone IIA-induced apoptosis in KBM-5 chronic myeloid leukemia cells Biol. Pharm. Bull. 36 2 2013 208 214
24. X. Wang, S. Yuan, and C. Wang A preliminary study of the anti-cancer effect of tanshinone on hepatic carcinoma and its mechanism of action in mice Zhonghua Zhong Liu Za Zhi 18 6 1996 412 414
25. H. Ma Novel microemulsion of tanshinone IIA: isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells Am. J. Chin. Med. 41 1 2013 197 210
26. C.Y. Huang Tanshinone IIA inhibits the growth of pancreatic cancer BxPC3 cells by decreasing protein expression of TCTP: MCL1 and BclxL Mol. Med. Rep. 7 3 2013 1045 1049
27. S.C. Chiu Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo Prostate Cancer Prostatic Dis. 16 4 2013 315 322
28. Y. Zhang Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling Pharm. Res. 29 6 2012 1595 1608
29. S.H. Won Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells Phytother. Res. 26 5 2012 669 674
30. S.H. Won Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway Biol. Pharm. Bull. 33 11 2010 1828 1834
31. Y. Zhou Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats Asian J. Androl. 11 4 2009 451 459
32. R. Yang Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia Asian J. Androl. 12 5 2010 735 743
33. R. Shao Epithelial-to-mesenchymal transition and estrogen receptor alpha mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia Prostate 74 9 2014 970 982
34. X. Wang Potential anticancer activity of tanshinone IIA against human breast cancer Int. J. Cancer 116 5 2005 799 807
35. Y.N. Kim Effect of Phellius linteus water extract on benign prostatic hyperplasia Nutr. Res. Pract. 7 3 2013 172 177
36. D.H. Xu Protective effects of seahorse extracts in a rat castration and testosterone-induced benign prostatic hyperplasia model and mouse oligospermatism model Environ. Toxicol. Pharmacol. 37 2 2014 679 688
37. H. Zhang, Y. Jing, and G. Wu Inhibitory effects of crude polysaccharides from Semen vaccariae on benign prostatic hyperplasia in mice J. Ethnopharmacol. 145 2 2013 667 669
38. W. Liu Antiandrogenic: maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A J. Med. Chem. 55 2 2012 971 975
39. C.C. Chiu, and T.L. Su Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential Int. J. Mol. Med. 25 2 2010 231 236
40. C.C. Cheng, and C.Y. Su Tanshinone IIA may inhibit the growth of small cell lung cancer H146 cells by up-regulating the Bax/Bcl-2 ratio and decreasing mitochondrial membrane potential Mol. Med. Rep. 3 4 2010 645 650
41. Z. Zhang Both nongenomic and genomic effects are involved in estradiol's enhancing the phenotype of smooth muscle cells in cultured prostate stromal cells Prostate 70 3 2010 317 332
42. S.J. Stone, and N.N. Clejan Response of prostate volume: prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia J. Androl. 12 6 1991 376 380
43. Z. Zhang The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK Prostate 68 5 2008 508 516
44. C.G. Roehrborn Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) Med. Clin. North Am. 95 1 2011 87 100
45. J. Pinheiro, and L.C. Martins Pisco Treatment of benign prostatic hyperplasia Tech. Vasc. Interv. Radiol. 15 4 2012 256 260
46. S.C. Chiu Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo Prostate Cancer Prostatic Dis. 16 4 2013 315 322
47. J.C. Nickel Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial J. Urol. 1 3 Pt 1 2007 896 900 (discussion 900-1)
48. G.W. Fan The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS J Steroid Biochem Mol. Biol. 113 3-5 2009 275 280
49. W.Y. Lee, L.C. Chiu, and J.H. Yeung Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation Food Chem. Toxicol. 46 1 2008 328 338
50. H. Wang, X. Gao, and B. Zhang Tanshinone: an inhibitor of proliferation of vascular smooth muscle cells J Ethnopharmacol. 99 1 2005 93 98
51. T.L. Pan Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells Proteomics 10 5 2014 914 929
52. J. Cai Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism Am. J. Physiol. Heart Circ. Physiol. 300 4 2011 H1210 H1221
53. J.T. Wu Androgen receptor is a potential therapeutic target for bladder cancer Urology 75 4 2010 820 827
54. H. Kikuchi ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells Carcinogenesis 28 8 2007 1752 1758
55. M.D. Planas-Silva, and R.A. Weinberg Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution Mol. Cell Biol. 17 7 1997 4059 4069
56. N.R. Wilcken Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens Clin. Cancer Res. 3 6 1997 849 854